Acute conjunctival inflammation in the newborn, usually caused by maternal gonococcal infection. The causative agent is NEISSERIA GONORRHOEAE. The baby's eyes are contaminated during passage through the birth canal.
Granulomatous uveitis which follows in one eye after a penetrating injury to the other eye; the secondarily affected eye is called the sympathizing eye, and the injured eye is called the exciting or activating eye.
A silver salt with powerful germicidal activity. It has been used topically to prevent OPHTHALMIA NEONATORUM.
Conjunctivitis is an inflammation or infection of the conjunctiva, the transparent membrane that lines the inner surface of the eyelids and covers the white part of the eye, resulting in symptoms such as redness, swelling, itching, burning, discharge, and increased sensitivity to light.
A severe, sometimes fatal, disorder of adipose tissue occurring chiefly in preterm or debilitated infants suffering from an underlying illness and manifested by a diffuse, nonpitting induration of the affected tissue. The skin becomes cold, yellowish, mottled, and inflexible.
An infection of the eyes characterized by the presence in conjunctival epithelial cells of inclusion bodies indistinguishable from those of trachoma. It is acquired by infants during birth and by adults from swimming pools. The etiological agent is CHLAMYDIA TRACHOMATIS whose natural habitat appears to be the genito-urinary tract. Inclusion conjunctivitis is a less severe disease than trachoma and usually clears up spontaneously.
An iodinated polyvinyl polymer used as topical antiseptic in surgery and for skin and mucous membrane infections, also as aerosol. The iodine may be radiolabeled for research purposes.
An infant during the first month after birth.
Purulent infections of the conjunctiva by several species of gram-negative, gram-positive, or acid-fast organisms. Some of the more commonly found genera causing conjunctival infections are Haemophilus, Streptococcus, Neisseria, and Chlamydia.
Inflammation, often mild, of the conjunctiva caused by a variety of viral agents. Conjunctival involvement may be part of a systemic infection.
Semisolid preparations used topically for protective emollient effects or as a vehicle for local administration of medications. Ointment bases are various mixtures of fats, waxes, animal and plant oils and solid and liquid hydrocarbons.

Microbiological study of neonatal conjunctivitis with special reference to Chlamydia trachomatis. (1/31)

PURPOSE: To study the microbial agents, chiefly Chlamydia trachomatis and other bacteria, in neonatal conjunctivitis. METHODS: Conjunctival specimens from 70 newborns with conjunctivitis were subjected to bacterial culture and sensitivity testing, monoclonal antibody based C. trachomatis antigen detection test and species-specific Chlamydia antibody detection in the sera of babies and their mothers, by micro-immunofluorescence assay. RESULTS: Bacteria were isolated from 35 (50%) babies; the majority (20, 57.14%) were Staphylococcus epidermidis. C. trachomatis antigen was detected in conjunctival smears of 17 (24%) babies, and 6 (35.29%) of them were positive for other bacteria. Six babies and their mothers tested positive for C. trachomatis Ig G antibodies. At follow-up after 14 weeks, 6 (35.29%) of the Chlamydia antigen-positive babies were found to have developed recurrent conjunctivitis. CONCLUSION: C. trachomatis is responsible for almost a quarter of all cases of neonatal conjunctivitis, with recurrences in 35% of cases. Bacteria could be isolated from 50% of the patients though the exact role of Staphylococcus epidermidis, isolated from 28.65% of the neonatal conjunctivitis cases, remains unclear.  (+info)

Transferring policies for treating sexually transmitted infections: what's wrong with global guidelines? (2/31)

The paper uses a case study of the development of syndromic management for treating sexually transmitted infections (STIs) and subsequent policies recommending worldwide use of syndromic management guidelines. These treatment policies emerged in the late 1970s from researchers and public health physicians working in sub-Saharan Africa where they had to treat large numbers of STIs in difficult circumstances. Syndromic management was initially developed in specific local epidemiological and resource situations. By the late 1980s, the World Health Organization had adopted syndromic management as policy, and began to promote it globally in the form of algorithms and training guidelines. Dissemination was assisted by the context of the rapid spread of HIV/AIDS and the apparent effectiveness of syndromic management for treating STIs and slowing the transmission of HIV/AIDS. In the mid 1990s, international donors interested in HIV control and women's reproductive health took it up, and encouraged national programmes to adopt the new guidelines. Implementation, however, was a great deal more complex than anticipated, and was exacerbated by differences between three rather separate policy networks involved in the dissemination and execution of the global guidelines. The analysis focuses on two parts of the process of policy transfer: the organic development of scientific and medical consensus around a new policy for the treatment of STIs; and the formulation and subsequent dissemination of international policy guidelines. Using a political science approach, we analyze the transition from clinical tools to global guidelines, and the associated debates that accompanied their use. Finally, we comment on the way current global guidelines need to be adapted, given the growth in knowledge.  (+info)

A double application approach to ophthalmia neonatorum prophylaxis. (3/31)

AIMS: To investigate if a second drop of 2.5% povidone-iodine ophthalmic solution placed within the first postnatal day would achieve better prophylaxis against ophthalmia neonatorum than a single drop applied at birth. METHODS: A masked, prospective, controlled trial was conducted over a 2 year period in a Kenyan hospital. Randomisation was achieved by alternating weeks of one or two eye drop application to both eyes. All 719 neonates received one drop of the povidone-iodine solution to both eyes at birth, while 317 received a second drop at hospital discharge or 24 (SD 4) hours after delivery, whichever was first. All infants developing conjunctivitis within a month after birth underwent microbiological analysis using Gram and Giemsa stains, direct fluorescent antibody assay for Chlamydia trachomatis, and culture. RESULTS: Of the neonates receiving the one eye drop application, 18.4% returned with a red eye with discharge, 4.0% had organisms found on the initial smear, and 8.2% had a positive culture. The corresponding proportions for the multidrop group were 24.3%, 4.7%, and 10.4%. Of those returning with an inflamed eye, there were no cases of Neisseria gonorrhoeae, 4.2% in the single dose group and 3.9% in the double dose group were positive for C trachomatis, and 5.4% and 6.5% respectively for Staphylococcus aureus. At discharge, the eyelid oedema score of the double dose group was mildly greater than the single dose group (1.4 (0.67) v 1.2 (0.73), p=0.0002). There was no statistically significant difference between the groups in any other category. CONCLUSION: There is no advantage to administering povidone-iodine prophylaxis against ophthalmia neonatorum twice in the first postnatal day over a single application at birth.  (+info)

The impact of national and international guidelines on newborn care in the nurseries of Piedmont and Aosta Valley, Italy. (4/31)

BACKGROUND: Care procedures for preventing neonatal diseases are carried out according to nurseries' traditions and may be not consistent with the evidence based medicine issues. METHODS: A multi-centric survey was conducted in 2 Regions located in NW Italy (Piedmont and Aosta Valley) in order to collect information on some healthy newborn care procedures. During 2001, a questionnaire was sent to the chief pediatrician in charge to the all 33 nurseries of the region asking the methods used during 2000 as prevention of ophthalmia neonatorum, early and late hemorrhagic disease of newborn, umbilical cord care and recommendations of vitamin D administration. Thereafter, during 2004 the same questionnaire was sent to the 34 chief pediatrician of nurseries to evaluate if the procedures were changed during 2003 according to guidelines. The nurseries care for 32,516 newborns in 2000 and 37,414 in 2003. RESULTS: Aminoglycoside eyes drops as prevention of ophthalmia neonatorum were the first choice in both periods (23 out 33 nurseries in 2000 and 24 out 34 in 2003 p > 0.05; the corresponding figures for newborns were 18,984 out 32,516 newborns vs. 28,180 out of 37,414 p < 0.05). The umbilical cord care was carried out with alcohol in 12/33 centers (13,248 newborns) and dry gauze in 3/33 centers (2,130 newborns) in 2000, the corresponding figures in 2003 were 6/34 centers (p > 0.05), (6,380 newborns, p < 0.05) and 12/34 centers (p < 0.05), (18,123 newborns, p < 0.05). The percentage of newborns receiving of i.m. vitamin K. at birth increased during the study period (15,923/32,104 in 2000 vs. 19,684/37,414 in 2003, p < 0.01), but not the number of nurseries (16 in 2000 and 17 in 2003 p > 0.05). The numbers of parents of newborns who receive the recommendations of oral vitamin K during the first months life decreased from 2000 (25,516/30,606) to 2003 (29,808/37,414, p < 0.01) as well as for Vitamin D recommendation (14,582/30,616 in 2000 vs. 11,051/37,414 in 2003, p < 0.01). Oral vitamin K during the first months of life was recommended by 25 nurseries in 2000 and 27 in 2003 (p > 0.05), the corresponding figures for Vitamin D were 15 and 14 (p > 0.05). CONCLUSION: In the present study a large variability of procedures among the nurseries was observed. During the study periods, guidelines and evidence based medicine issues have only partially modified the neonatal care procedures In Piedmont and Aosta Valley nurseries. These observations suggest to implement local forum/consensus conference to standardized procedures as much as possible.  (+info)

Recent trends in chlamydial and gonococcal conjunctivitis among neonates and adults in an Irish hospital. (5/31)

BACKGROUND: Chlamydia trachomatis and Neisseria gonorrhoeae are two important and frequently overlooked causes of neonatal and adult conjunctivitis. OBJECTIVES AND METHODS: In order to improve primary treatment, prevention, and control of infection caused by these organisms, an analysis of all cases presenting from July 2002 to December 2006 at a major Irish regional teaching hospital was performed. RESULTS: There were 51 cases of conjunctivitis in total. Among neonates and adults, C. trachomatis was the most common cause of conjunctivitis. Of the adult patients, 75% were men. The annual incidence of adult chlamydial conjunctivitis increased yearly from 2002 and correlated with an overall increase in genital chlamydia infection in the region. Neonatal chlamydial conjunctivitis has an overall incidence of 0.65/1000 live births and is continuing to rise annually. In 2006, gonococcal conjunctivitis accounted for 20% of all cases of conjunctivitis caused by sexually transmitted bacteria presenting to our hospital. CONCLUSIONS: The recent increase in the incidence of gonococcal keratitis serves to remind us that this important infection should be borne in mind when treating cases of purulent conjunctivitis. The diagnosis of chlamydial and gonococcal conjunctivitis requires a high index of suspicion and prompt treatment with systemic antibiotics.  (+info)

Ophthalmia neonatorum caused by Neisseria cinerea. (6/31)

Neisseria cinerea is an organism that has only recently been implicated as a human pathogen. In this case, N. cinerea was identified as the cause of ophthalmia neonatorum (conjunctivitis) in a 2-day-old girl.  (+info)

Treatment and prevention of ophthalmia neonatorum. (7/31)

QUESTION: In my office I occasionally see neonates with conjunctivitis. What are the current recommendations for ocular prophylaxis at birth? Do topical antibiotics alone provide adequate treatment of neonatal conjunctivitis? When is systemic therapy indicated? ANSWER: All infants should receive ocular prophylaxis at birth to prevent gonococcal ophthalmia. Neonates presenting with signs of conjunctivitis should have a conjunctival swab sent for Gram stain and culture. If Gram-negative diplococci are present on the Gram stain results, the infants and their parents should be treated immediately for presumed gonorrhea. Infants with chlamydial infection should be treated with oral antibiotics. Most of all other forms of bacterial conjunctivitis can be treated with topical antibiotics, with the exception of Pseudomonas infection. Infants should be followed during their treatment and upon completion of therapy to ensure resolution of symptoms. For cases in which sexually transmitted bacteria are implicated, the mothers and their sexual partners should be treated.  (+info)

Epidemiology and control of gonococcal ophthalmia neonatorum. (8/31)

From a public health point of view gonococcal ophthalmia neonatorum (GCON) is important as it can rapidly lead to blindness. The frequency of GCON is determined by the prevalence of maternal gonococcal infection. In most industrialized countries the prevalence of gonorrhoea in pregnant women is less than 1%; in developing countries the rates are between 3% and 15%, more than 50% being due to penicillinase-producing Neisseria gonorrhoeae strains (PPNG). The rate of transmission from mother to newborn is between 30% and 50%. Strategies for the control of GCON include: (1) prevention of gonococcal infection in women of childbearing age, (2) detection and treatment of gonococcal infection in pregnant women, (3) eye prophylaxis in the newborn at birth, and (4) diagnosis and treatment of GCON. Eye prophylaxis by the instillation immediately after birth of either 1% silver nitrate eye drops or 1% tetracycline eye ointment is very effective. This reduces the GCON incidence by 80% to 95% and is highly cost-effective, particularly in high-risk settings.  (+info)

Ophthalmia Neonatorum is a medical term that refers to a conjunctivitis (inflammation of the conjunctiva) occurring in the first 28 days of life, often presenting with purulent discharge and redness of the eye. It can be caused by various microorganisms, including bacteria such as Neisseria gonorrhoeae, Chlamydia trachomatis, or bacterial flora from the mother's birth canal or hospital environment. Immediate treatment is necessary to prevent potential blindness and other complications. Prophylaxis with erythromycin ointment is often recommended for all newborns.

Sympathetic ophthalmia is a rare inflammatory condition that can occur in the eye after trauma or surgery to the other eye. It is caused by an autoimmune response where the immune system mistakenly attacks the healthy eye tissues, thinking they are similar to the damaged tissues in the other eye. This condition can lead to severe inflammation, including redness, pain, light sensitivity, and potentially vision loss if not treated promptly and effectively with immunosuppressive therapy. Sympathetic ophthalmia typically develops within several weeks to a few months after the initial injury or surgery, but it can occur even years later.

Silver nitrate is defined as an inorganic compound with the chemical formula AgNO3. It is a white or colorless crystalline solid that is highly soluble in water. Silver nitrate is commonly used in medicine as a topical antiseptic and caustic, particularly for the treatment of wounds, ulcers, and warts. When applied to skin or mucous membranes, it can help to destroy bacteria, viruses, and fungi, and promote healing. However, it can also cause irritation and tissue damage if used inappropriately, so it should be used with caution and under the guidance of a healthcare professional.

Conjunctivitis is an inflammation or infection of the conjunctiva, a thin, clear membrane that covers the inner surface of the eyelids and the outer surface of the eye. The condition can cause redness, itching, burning, tearing, discomfort, and a gritty feeling in the eyes. It can also result in a discharge that can be clear, yellow, or greenish.

Conjunctivitis can have various causes, including bacterial or viral infections, allergies, irritants (such as smoke, chlorine, or contact lens solutions), and underlying medical conditions (like dry eye or autoimmune disorders). Treatment depends on the cause of the condition but may include antibiotics, antihistamines, anti-inflammatory medications, or warm compresses.

It is essential to maintain good hygiene practices, like washing hands frequently and avoiding touching or rubbing the eyes, to prevent spreading conjunctivitis to others. If you suspect you have conjunctivitis, it's recommended that you consult an eye care professional for a proper diagnosis and treatment plan.

Sclerema Neonatorum is a rare, but serious condition that primarily affects newborns and infants. It is characterized by extensive hardening (sclerosis) and thickening of the subcutaneous fat tissue, which gives the skin a wood-like or waxen appearance and texture. This process can occur quite rapidly, often within hours to days.

The exact cause of Sclerema Neonatorum is not fully understood, but it's more commonly seen in premature babies, those with low birth weight, and those who have serious underlying medical conditions such as sepsis, pneumonia, or meningitis. It's thought to be a result of an abnormal response of the body's immune system to these conditions.

The condition can be difficult to treat, and mortality rates are high, particularly if there are underlying severe illnesses. Treatment typically involves addressing any underlying infections, providing supportive care to maintain body temperature, nutrition, and hydration, and in some cases, the use of medications to help soften the affected tissue.

Inclusion conjunctivitis is a type of bacterial conjunctivitis (inflammation of the conjunctiva) that is caused by specific types of bacteria, most commonly Chlamydia trachomatis. It is also known as trachoma, which is a leading infectious cause of blindness worldwide. The infection leads to the formation of small, inclusion-containing intracytoplasmic inclusions in the conjunctival epithelial cells, hence the name "inclusion conjunctivitis."

The symptoms of inclusion conjunctivitis include redness, irritation, and discharge from the eyes. It can also cause swelling of the lymph nodes near the ears. In severe cases, it can lead to scarring and damage to the cornea, potentially resulting in vision loss. The infection is typically spread through direct contact with eye or nose discharge from an infected person, and it can also be sexually transmitted.

Treatment for inclusion conjunctivitis usually involves antibiotics, such as azithromycin or doxycycline, to eliminate the bacteria causing the infection. It is important to complete the full course of treatment to ensure that the infection is fully cleared and to prevent recurrence. In addition, good hygiene practices, such as frequent handwashing and avoiding sharing personal items like towels and washcloths, can help prevent the spread of the infection.

Povidone-Iodine is a broad-spectrum antimicrobial agent, which is a complex of iodine with polyvinylpyrrolidone (PVP). This complex allows for sustained release of iodine, providing persistent antimicrobial activity. It has been widely used in various clinical settings, including as a surgical scrub, wound disinfection, and skin preparation before invasive procedures. Povidone-Iodine is effective against bacteria, viruses, fungi, and spores. The mechanism of action involves the release of iodine ions, which oxidize cellular components and disrupt microbial membranes, leading to cell death.

A newborn infant is a baby who is within the first 28 days of life. This period is also referred to as the neonatal period. Newborns require specialized care and attention due to their immature bodily systems and increased vulnerability to various health issues. They are closely monitored for signs of well-being, growth, and development during this critical time.

Bacterial conjunctivitis is a type of conjunctivitis (inflammation of the conjunctiva) that is caused by bacterial infection. The most common bacteria responsible for this condition are Staphylococcus aureus, Streptococcus pneumoniae, and Haemophilus influenzae.

The symptoms of bacterial conjunctivitis include redness, swelling, and pain in the eye, along with a thick, sticky discharge that can cause the eyelids to stick together, especially upon waking up. Other symptoms may include tearing, itching, and sensitivity to light. Bacterial conjunctivitis is highly contagious and can spread easily through contact with infected individuals or contaminated objects such as towels, handkerchiefs, or makeup.

Treatment for bacterial conjunctivitis typically involves the use of antibiotic eye drops or ointments to eliminate the infection. In some cases, oral antibiotics may also be prescribed. It is important to seek medical attention if you suspect that you have bacterial conjunctivitis, as untreated infections can lead to serious complications such as corneal ulcers and vision loss.

Viral conjunctivitis is an inflammation of the conjunctiva, the thin membrane that covers the white part of the eye (sclera) and the inner surface of the eyelids, caused by a viral infection. The condition is often characterized by redness, watering, gritty or burning sensation in the eyes, and a clear, watery discharge. In some cases, it may also cause swelling of the eyelids and light sensitivity.

The most common viruses that can cause conjunctivitis are adenoviruses, which are responsible for about 65-90% of all viral conjunctivitis cases. Other viruses that can cause the condition include herpes simplex virus, varicella-zoster virus (which causes chickenpox and shingles), and picornaviruses.

Viral conjunctivitis is highly contagious and can spread easily through direct contact with infected individuals or contaminated surfaces. It typically affects one eye first and then spreads to the other eye within a few days. The condition usually resolves on its own within 1-2 weeks, although in some cases it may take longer to clear up completely.

There is no specific treatment for viral conjunctivitis, and antibiotics are not effective against viral infections. However, cool compresses and artificial tears can help alleviate symptoms such as discomfort and dryness. It is important to practice good hygiene, such as washing hands frequently and avoiding touching the eyes, to prevent the spread of the virus to others.

An ointment is a semi-solid preparation, typically composed of a mixture of medicinal substance with a base, which is usually greasy or oily. The purpose of the base is to act as a vehicle for the active ingredient and allow it to be applied smoothly and evenly to the skin or mucous membranes.

Ointments are commonly used in dermatology to treat various skin conditions such as eczema, psoriasis, rashes, burns, and wounds. They can also be used to deliver medication for localized pain relief, muscle relaxation, and anti-inflammatory or antibiotic effects.

The base of an ointment may consist of various ingredients, including petrolatum, lanolin, mineral oil, beeswax, or a combination of these. The choice of the base depends on the desired properties such as consistency, spreadability, and stability, as well as the intended route of administration and the specific therapeutic goals.

  • Neonatal conjunctivitis, also known as ophthalmia neonatorum, presents during the first month of life. (medscape.com)
  • Iwata, S 1999, ' Ophthalmia neonatorum (neonatal conjunctivitis) ', Ryōikibetsu shōkōgun shirīzu , no. 25 Pt 3, pp. 181-182. (elsevierpure.com)
  • They also may be used to prevent certain eye infections of newborn babies, such as neonatal conjunctivitis and ophthalmia neonatorum. (mayoclinic.org)
  • Ophthalmia neonatorum is a severe form of bacterial conjunctivitis that occurs in newborn babies. (aoa.org)
  • Ophthalmia Neonatorum Caused by C. trachomatis A chlamydial etiology should be considered for all infants with conjunctivitis through 30 days of age. (cdc.gov)
  • Ophthalmia neonatorum is caused by C. trachomatis subtypes D through K. Ophthalmia neonatorum is a less severe infection than adult conjunctivitis (trachoma), but if not treated early it can cause superficial keratitis, otitis, and pneumonia in the neonate. (aafp.org)
  • and transmission to the neonate with attendant conjunctivitis (ophthalmia neonatorum). (medscape.com)
  • Neonatal ophthalmia is a potentially serious, sight-threatening infection that may be caused by sexually transmitted pathogens. (cdc.gov)
  • A specific diagnosis of C. trachomatis infection confirms the need for chlamydial treatment not only for the neonate, but also for the mother and her sex partner(s). (cdc.gov)
  • TheWHO/PBLeyeexamination andeyeservices.Inthepoorestcoun- Inthisdescriptivestudy,theAbabasir recordforchildrenwithblindnessand tries of the world, corneal scarring SchoolfortheBlindwasvisiteddur- lowvisionwasused[ 6 ].Thisclassifies duetovitaminAdeficiency,measles ingtheacademicyear2006,between causeaccordingtothemainanatomical infection, ophthalmia neonatorum, October 2005 and June 2006, after siteoftheabnormalityaswel asthe andtheeffectsofharmfultraditional obtainingpermissionforthestudyfrom underlyingetiology. (who.int)
  • The use of CILOXAN eye drops in neonates with ophthalmia neonatorum of gonococcal or chalamydial origin is not recommended as it has not been evaluated in such patients. (medicines.org.uk)
  • Neonates with ophthalmia neonatorum should receive appropriate treatment for their condition. (medicines.org.uk)
  • Gonococcal ophthalmia neonatorum needs prompt treatment to prevent complications. (wikipedia.org)
  • It is also important to remember that prenatal screening is the best method for preventing gonococcal ophthalmia neonatorum among newborns! (cdc.gov)
  • Antibiotic prophylaxis for ophthalmia neonatorum in Italy: results from a national survey and the Italian intersociety new position statements. (nih.gov)
  • Universal ophthalmia neonatorum prophylaxis in Ontario: a cost-effectiveness analysis. (nih.gov)
  • However, ocular prophylaxis with those agents does prevent gonococcal ophthalmia and should be continued for that reason (see Prevention of Ophthalmia Neonatorum). (cdc.gov)
  • Case series and literature review of chlamydial ophthalmia neonatorum in Botswana. (nih.gov)
  • Diagnostic Considerations - Sensitive and specific methods to diagnose chlamydial ophthalmia for the neonate include isolation by tissue culture and nonculture tests, direct fluorescent antibody tests, and immunoassays. (cdc.gov)
  • Antibiotic ointment is typically applied to the newborn's eyes within 1 hour of birth as prevention for gonococcal ophthalmia. (wikipedia.org)
  • Then, in 1884 Carl Crede used 1% silver nitrate to prevent ophthalmia neonatorum. (positivehealth.com)
  • citation needed] Ophthalmia neonatorum due to gonococci (N. gonorrhoeae) typically manifests in the first 5 days after birth and is associated with marked bilateral purulent discharge and local inflammation. (wikipedia.org)
  • Ophthalmia neonatorum occurs when an infant is exposed to chlamydia or gonorrhea while passing through the birth canal. (aoa.org)
  • He was admitted to the hospital for presumed ophthalmia neonatorum. (cdc.gov)
  • Chemical ophthalmia neonatorum is a self-limiting condition and does not require any treatment. (wikipedia.org)
  • when affecting the infant's eyes, it is referred to as ophthalmia neonatorum. (doctors.am)
  • While cases of nongonococcal, nonchlamydial, neonatal ophthalmia have been reported in which the causative agent was M. catarrhalis ( 7 , 8 ), to our knowledge, this case is the first report of neonatal ophthalmia due to M. osloensis . (cdc.gov)
  • This graph shows the total number of publications written about "Ophthalmia Neonatorum" by people in this website by year, and whether "Ophthalmia Neonatorum" was a major or minor topic of these publications. (wakehealth.edu)
  • Neonatal conjunctivitis, also known as ophthalmia neonatorum, presents during the first month of life. (medscape.com)
  • Ophthalmia neonatorum is conjunctivitis occurring in a newborn during the first month of life. (mims.com)
  • Types include sympathetic ophthalmia (inflammation of both eyes following trauma to one eye), gonococcal ophthalmia, trachoma or "Egyptian" ophthalmia, ophthalmia neonatorum (a conjunctivitis of the newborn due to either of the two previous pathogens), photophthalmia and actinic conjunctivitis (inflammation resulting from prolonged exposure to ultraviolet rays), and others. (wikipedia.org)
  • This can cause ophthalmia neonatorum (conjunctivitis) or pneumonia in some infants. (cdc.gov)
  • Ophthalmia neonatorum is a severe form of bacterial conjunctivitis that occurs in newborn babies. (aoa.org)
  • Ophthalmia Neonatorum Caused by C. trachomatis A chlamydial etiology should be considered for all infants with conjunctivitis through 30 days of age. (cdc.gov)
  • MOXIVIG should not be used for the prophylaxis or empiric treatment of gonococcal conjunctivitis, including gonococcal ophthalmia neonatorum, because of the prevalence of fluoroquinolone-resistant Neisseria gonorrhoeae . (medicines.org.uk)
  • Erythromycin eye ointment is commonly used in hospitals immediately following a baby's birth to prevent infection of the eyes, such as neonatal conjunctivitis or called ophthalmia neonatorum . (modernalternativemama.com)
  • Single-dose cefotaxime intramuscularly cures gonococcal ophthalmia neonatorum. (bmj.com)
  • Nine neonates with culture proved gonococcal ophthalmia neonatorum were treated with a single intramuscular injection of 100 mg/kg of cefotaxime without topical antibiotic therapy. (bmj.com)
  • However, ocular prophylaxis with those agents does prevent gonococcal ophthalmia and should be continued for that reason (see Prevention of Ophthalmia Neonatorum). (cdc.gov)
  • Ophthalmia neonatorum occurs when an infant is exposed to chlamydia or gonorrhea while passing through the birth canal. (aoa.org)
  • Chlamydia is the most frequent identifiable infectious cause of ophthalmia neonatorum. (cdc.gov)
  • Infants infected with chlamydia may develop ophthalmia neonatorum and/or pneumonia. (chlamydiaexplained.com)
  • Prevention of Neonatal Ophthalmia. (medscape.com)
  • While cases of nongonococcal, nonchlamydial, neonatal ophthalmia have been reported in which the causative agent was M. catarrhalis ( 7 , 8 ), to our knowledge, this case is the first report of neonatal ophthalmia due to M. osloensis . (cdc.gov)
  • Dr. Warlomont (Brussels) presented a paper on " Sympathetic Ophthalmia," which gave rise to a long discussion, lasting till 1.30, P.M., when an adjournment took place. (nih.gov)
  • The effectiveness of erythromycin in the prevention of ophthalmia caused by penicillinase-producing N. gonorrhoeae is not established. (nih.gov)
  • Diagnostic Considerations - Sensitive and specific methods to diagnose chlamydial ophthalmia for the neonate include isolation by tissue culture and nonculture tests, direct fluorescent antibody tests, and immunoassays. (cdc.gov)
  • Severe cases of ophthalmia can cause blindness if not treated, especially in newborns, who contract it from the environment in the womb. (wikipedia.org)
  • Now it's not used in the U.S., and doctors only use the antibiotic erythromycin to prevent ophthalmia neonatorum. (modernalternativemama.com)
  • He was admitted to the hospital for presumed ophthalmia neonatorum. (cdc.gov)

No images available that match "ophthalmia neonatorum"